Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Int J Mol Sci ; 22(22)2021 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-34830314

RESUMO

The kidney is one of the most susceptible organs to age-related impairments. Generally, renal aging is accompanied by renal fibrosis, which is the final common pathway of chronic kidney diseases. Aristolochic acid (AA), a nephrotoxic agent, causes AA nephropathy (AAN), which is characterized by progressive renal fibrosis and functional decline. Although renal fibrosis is associated with renal aging, whether AA induces renal aging remains unclear. The aim of the present study is to investigate the potential use of AAN as a model of renal aging. Here, we examined senescence-related factors in AAN models by chronically administering AA to C57BL/6 mice. Compared with controls, the AA group demonstrated aging kidney phenotypes, such as renal atrophy, renal functional decline, and tubulointerstitial fibrosis. Additionally, AA promoted cellular senescence specifically in the kidneys, and increased renal p16 mRNA expression and senescence-associated ß-galactosidase activity. Furthermore, AA-treated mice exhibited proximal tubular mitochondrial abnormalities, as well as reactive oxygen species accumulation. Klotho, an antiaging gene, was also significantly decreased in the kidneys of AA-treated mice. Collectively, the results of the present study indicate that AA alters senescence-related factors, and that renal fibrosis is closely related to renal aging.


Assuntos
Envelhecimento/efeitos dos fármacos , Ácidos Aristolóquicos/farmacologia , Colágeno/genética , Rim/efeitos dos fármacos , Nefrite Intersticial/induzido quimicamente , Insuficiência Renal Crônica/induzido quimicamente , Envelhecimento/genética , Animais , Colágeno/agonistas , Colágeno/metabolismo , Inibidor p16 de Quinase Dependente de Ciclina/genética , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Modelos Animais de Doenças , Fibrose , Regulação da Expressão Gênica , Humanos , Rim/metabolismo , Rim/patologia , Proteínas Klotho/genética , Proteínas Klotho/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Mitocôndrias/patologia , Nefrite Intersticial/genética , Nefrite Intersticial/metabolismo , Nefrite Intersticial/patologia , Espécies Reativas de Oxigênio/agonistas , Espécies Reativas de Oxigênio/metabolismo , Insuficiência Renal Crônica/genética , Insuficiência Renal Crônica/metabolismo , Insuficiência Renal Crônica/patologia , Transdução de Sinais , Fator de Crescimento Transformador beta/agonistas , Fator de Crescimento Transformador beta/genética , Fator de Crescimento Transformador beta/metabolismo , beta-Galactosidase/genética , beta-Galactosidase/metabolismo
2.
Int Immunopharmacol ; 97: 107614, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33892299

RESUMO

Overexposure to ultraviolet B (UVB) rays can cause damage to the skin. Liquiritin has a variety of pharmacological effects, such as anti-inflammatory and antioxidant. In the present study, the effect of liquiritin on UVB irradiated rat skin was investigated. Results showed that UVB irradiation caused erythema and wrinkles on the skin surface, as well as thickening and loss of elasticity of the epidermis and a significant increase in the level of ROS in the skin tissue. At the same time, western blot detected an increase in nuclear factor kappa-B (NF-κB) and matrix metalloproteinases (MMPs) and Elisa also detected an increase in pro-inflammatory factors. Therefore, we hypothesized that UVB irradiation-induced damage is associated with inflammation. Interestingly, application of liquiritin to exposed skin of rats reduced the increase in ROS, pro-inflammatory factors, and MMPs caused by UVB irradiation and increased the levels of Sirtuin3 (SIRT3) and Collagen α1. In addition, after intraperitoneal injection of the SIRT3 inhibitor 3-TYP in rats, the protective effect of liquiritin against UVB damage was found to be diminished. These results suggested that promotion of SIRT3 with liquiritin inhibits UVB-induced production of pro-inflammatory mediators, possibly acting through the SIRT3/ROS/NF-κB pathway. In conclusion, this study suggests that liquiritin is an effective drug candidate for the prevention of UVB damage.


Assuntos
Flavanonas , Glucosídeos , Transtornos de Fotossensibilidade , Neoplasias Cutâneas , Pele , Raios Ultravioleta , Animais , Humanos , Ratos , Colágeno/agonistas , Colágeno/metabolismo , Modelos Animais de Doenças , Flavanonas/farmacologia , Flavanonas/uso terapêutico , Glucosídeos/farmacologia , Glucosídeos/uso terapêutico , NF-kappa B/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/imunologia , Transtornos de Fotossensibilidade/etiologia , Transtornos de Fotossensibilidade/patologia , Transtornos de Fotossensibilidade/prevenção & controle , Proteólise/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Sirtuínas/metabolismo , Pele/efeitos dos fármacos , Pele/imunologia , Pele/patologia , Pele/efeitos da radiação , Neoplasias Cutâneas/etiologia , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/prevenção & controle , Raios Ultravioleta/efeitos adversos
3.
Arq. bras. med. vet. zootec. (Online) ; 71(3): 791-796, May-June 2019. tab, ilus
Artigo em Inglês | VETINDEX, LILACS | ID: biblio-1011303

RESUMO

In this essay, we quantify the concentration of collagen fibers in broiler chickens exposed to increasing concentrations of cupuacu seed by-product. Collection of material was carried out in five chickens per treatment at 70 days old in the groups: control, 5% and 10% inclusion of cupuacu seed by-product. Fragments of Thoracic Pectoralis (PT) and Iliotibial lateralis (ITL) muscles were prepared for light and electronic microscopy. The amount of collagen fibers in the muscle groups was 1.08±0.61% in the PTC group; 6.24±2.58% in PT5% and 7.30±2.75% in PT10%. In the Iliotibial Lateralis groups, the results were 6.96±3.14% in the ITLC; 7.43±4.22% in the ITL5% and 8.66±2.35% in ITL10%. The amount of collagen fibers in the ITL5% and ITL10% groups showed no significant statistical difference. However, when compared to the ILTC group, there was a significant statistical difference. The PT muscle responds to standard nutritional changes, unlike the ILT muscle, which requires a high-nutrient formulation. The use of 5% cupuacu seed by-product has proven to be a viable alternative source of animal feed, as it promotes an increase in the concentrations of collagen fibers in the musculature of broiler chickens and is possibly the determining factor in meat texture.(AU)


Neste estudo, foram quantificadas as concentrações de fibras colágenas de frangos expostos a crescentes concentrações de farinha de cupuaçu. A coleta de material foi realizada em cinco animais por tratamento, aos 70 dias de idade, nos grupos: controle, inclusão de 5% e de 10% de farinha de cupuaçu. Fragmentos dos músculos peitoral torácico (PT) e iliotibial lateral (ITL) foram preparados para microscopia de luz e eletrônica. A quantidade de fibras colágenas nos grupos foi: 1,08±0,61% no grupo PTC; 6,24±2,58% em PT5% e 7,30±2,75% em PT10%. Nos grupos iliotibial lateral, os resultados foram: 6,96±3,14% no ITLC; 7,43±4,22% no ITL5% e 8,66±2,35% em ITL10%. A quantidade de fibras colágenas nos grupos ITL5% e ITL10% não apresentou diferença estatística significativa. No entanto, quando comparados ao grupo ILTC, houve diferença estatística significativa. O músculo PT responde a mudanças nutricionais padrão, ao contrário do músculo ILT, que requer alta formulação nutricional. O uso de 5% de farinha de cupuaçu provou ser uma fonte alternativa viável de alimentação animal, pois promove um aumento nas concentrações de fibras de colágeno na musculatura de frangos de corte e é possivelmente um fator determinante na textura da carne.(AU)


Assuntos
Animais , Colágeno/agonistas , Pró-Colágeno/agonistas , Dieta/veterinária , Ração Animal , Carne/análise , Galinhas
4.
Artif Cells Nanomed Biotechnol ; 45(3): 591-597, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28211300

RESUMO

The aim of this study was to investigate the wound healing effects of clove oil (CO) via its encapsulation into nanoemulsion. Optimized nanoemulsion (droplet size of 29.10 nm) was selected for wound healing investigation, collagen determination, and histopathological examination in rats. Optimized nanoemulsion presented significant would healing effects in rats as compared to pure CO. Nanoemulsion also presented significant enhancement in leucine content (0.61 mg/g) as compared to pure CO (0.50 mg/g) and negative control (0.31 mg/g). Histopathology of nanoemulsion treated rats showed no signs of inflammatory cells. These results suggested that nanoemulsion of CO was safe and nontoxic.


Assuntos
Antibacterianos/farmacologia , Óleo de Cravo/farmacologia , Pele/efeitos dos fármacos , Cicatrização/efeitos dos fármacos , Animais , Antibacterianos/química , Óleo de Cravo/química , Colágeno/agonistas , Colágeno/biossíntese , Emulsões , Feminino , Glicerídeos/química , Nanoestruturas , Tamanho da Partícula , Polissorbatos/química , Ratos , Ratos Wistar , Pele/lesões , Triacetina/química , Cicatrização/fisiologia
5.
Toxicol Lett ; 260: 52-69, 2016 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-27521499

RESUMO

Tributyltin chloride (TBT) is an organometallic pollutant that is used as a biocide in antifouling paints. TBT induces several toxic and endocrine-disrupting effects. However, studies evaluating the effects of TBT on renal function are rare. This study demonstrates that TBT exposure is responsible for improper renal function as well as the development of abnormal morphophysiology in mammalian kidneys. Female rats were treated with TBT, and their renal morphophysiology was assessed. Morphophysiological abnormalities such as decreased glomerular filtration rate and increased proteinuria levels were observed in TBT rats. In addition, increases in inflammation, collagen deposition and α-smooth muscle actin (α-SMA) protein expression were observed in TBT kidneys. A disrupted cellular redox balance and apoptosis in kidney tissue were also observed in TBT rats. TBT rats demonstrated reduced serum estrogen levels and estrogen receptor-α (ERα) protein expression in renal cortex. Together, these data provide in vivo evidence that TBT is toxic to normal renal function and that these effects may be associated with renal histopathology complications, such as inflammation and fibrosis.


Assuntos
Desinfetantes/toxicidade , Poluentes Ambientais/toxicidade , Rim/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Insuficiência Renal/induzido quimicamente , Compostos de Trialquitina/toxicidade , Actinas/agonistas , Actinas/metabolismo , Animais , Apoptose/efeitos dos fármacos , Biomarcadores/sangue , Biomarcadores/metabolismo , Biomarcadores/urina , Colágeno/agonistas , Colágeno/metabolismo , Desinfetantes/administração & dosagem , Relação Dose-Resposta a Droga , Disruptores Endócrinos/toxicidade , Poluentes Ambientais/administração & dosagem , Receptor alfa de Estrogênio/antagonistas & inibidores , Receptor alfa de Estrogênio/metabolismo , Estrogênios/sangue , Feminino , Fibrose , Rim/imunologia , Rim/patologia , Rim/fisiopatologia , Mastócitos/efeitos dos fármacos , Mastócitos/imunologia , Mastócitos/patologia , Proteinúria/etiologia , Ratos Wistar , Insuficiência Renal/imunologia , Insuficiência Renal/patologia , Insuficiência Renal/fisiopatologia , Estanho/sangue , Toxicocinética , Compostos de Trialquitina/administração & dosagem
6.
J Physiol Biochem ; 72(2): 213-23, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26896308

RESUMO

The proliferation of cardiac fibroblasts (CFs) and excessive deposition of extracellular matrix (ECM) are the main pathological characteristics of cardiac fibrosis. In recent years, microRNAs (miRNAs) have been found to be a new kind of regulator in cardiac fibrosis. The purpose of this study was to investigate the role of microRNA-9 (miR-9) in the process of cardiac fibrosis and its mechanism. Treatment of cultured neonatal rat CFs with PDGF-BB or serum suppressed the expression of miR-9. Overexpression of miR-9 obviously inhibited neonatal rat CFs proliferation and collagen production as detected by MTT assays, qRT-PCR, and western blotting. The effects of miR-9 in CFs were abrogated by co-transfection with miR-9 inhibitors. Overexpression of miR-9 reduced the mRNA and protein levels of PDGFR-ßand its downstream protein, extracellular signal-regulated kinase (ERK) 1/2. Silencing PDGFR-ßby small interfering RNA mimicked the anti-fibrotic action of miR-9, whereas overexpression of PGDFR-ß canceled the effect of miR-9 in cultured CFs. Dual-luciferase reporter assays showed that PDGFR-ßwas a direct target of miR-9. Overexpression of miR-9 inhibited cardiac fibrosis by targeting PDGFR-ß, indicating that miR-9 might play a role in the treatment of cardiac fibrosis.


Assuntos
Fibrose Endomiocárdica/metabolismo , MicroRNAs/metabolismo , Miofibroblastos/metabolismo , Interferência de RNA , Receptor beta de Fator de Crescimento Derivado de Plaquetas/antagonistas & inibidores , Regiões 3' não Traduzidas/efeitos dos fármacos , Indutores da Angiogênese/farmacologia , Animais , Animais Recém-Nascidos , Antagomirs/metabolismo , Antagomirs/farmacologia , Becaplermina , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Colágeno/agonistas , Colágeno/antagonistas & inibidores , Colágeno/genética , Colágeno/metabolismo , Fibrose Endomiocárdica/tratamento farmacológico , Fibrose Endomiocárdica/patologia , Regulação da Expressão Gênica/efeitos dos fármacos , Genes Reporter/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , MicroRNAs/antagonistas & inibidores , Miofibroblastos/efeitos dos fármacos , Miofibroblastos/patologia , Proteínas Proto-Oncogênicas c-sis/farmacologia , Interferência de RNA/efeitos dos fármacos , RNA Interferente Pequeno , Ratos Sprague-Dawley , Receptor beta de Fator de Crescimento Derivado de Plaquetas/genética , Receptor beta de Fator de Crescimento Derivado de Plaquetas/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia
7.
Langmuir ; 31(15): 4490-5, 2015 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-25835126

RESUMO

The self-assembly and bioactivity of a peptide amphiphile (PA) incorporating a 13-residue sequence derived from the last 13 amino acids of the C-terminus of lumican, C16-YEALRVANEVTLN, attached to a hexadecyl (C16) lipid chain have been examined. Lumican is a proteoglycan found in many types of tissue and is involved in collagen fibril organization. A critical aggregation concentration (cac) for the PA was determined through pyrene fluorescence measurements. The structure of the aggregates was imaged using electron microscopy, and twisted and curved nanotapes were observed. In situ small-angle X-ray scattering and fiber X-ray diffraction reveal that these tapes contain interdigitated bilayers of the PA molecules. FTIR and circular dichroism spectroscopy and fiber X-ray diffraction indicate that the lumican sequence in the PA adopts a ß-sheet secondary structure. Cell assays using human dermal fibroblasts show that below the cac the PA displays good biocompatibility and also stimulates collagen production over a period of 3 weeks, exceeding a 2-fold enhancement for several concentrations. Thus, this PA has promise in future biological applications, in particular, in tissue engineering.


Assuntos
Proteoglicanas de Sulfatos de Condroitina/química , Colágeno/agonistas , Sulfato de Queratano/química , Peptídeos/farmacologia , Sequência de Aminoácidos , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Colágeno/biossíntese , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Corantes Fluorescentes , Humanos , Lumicana , Dados de Sequência Molecular , Peptídeos/síntese química , Estrutura Secundária de Proteína , Pirenos
8.
Neuroreport ; 26(5): 273-8, 2015 Mar 25.
Artigo em Inglês | MEDLINE | ID: mdl-25730677

RESUMO

The pedunculopontine nucleus (PPN) is a part of the reticular activating system and one of the main sources of the cholinergic fibers in the midbrain, while it is also subject to cholinergic modulation. This nucleus is known to be a structure that controls sleep-wake cycles, arousal, and locomotion. Neurons of the PPN are targets of several neuromodulatory mechanisms, which elicit heterogeneous pharmacological responses including hyperpolarization and depolarization, whereas lack of response can also be observed. In agreement with previous findings, we found that PPN neurons respond to the muscarinic agonist carbachol in a heterogeneous manner: they were depolarized and showed increased firing rate, decreased firing frequency, and were hyperpolarized, or showed no response. The heterogeneity of the muscarinic activation was similar to our previous observations with type 1 cannabinoid (CB1) receptor agonists; therefore, we investigated whether muscarinic and endocannabinoid modulatory mechanisms elicit the same action on a certain neuron. To achieve this, whole-cell patch clamp experiments were conducted on midbrain slices containing the PPN. Carbachol was applied first and, after recording the changes in the membrane potential and the firing frequency and achieving washout, the CB1 receptor agonist arachidonyl-2'-chloroethylamide (ACEA) was applied. A marked but not full overlap was observed: all neurons depolarized by carbachol were depolarized by the CB1 receptor agonist ACEA, and all neurons lacking response to carbachol lacked response to ACEA as well. However, neurons hyperpolarized by carbachol were depolarized, hyperpolarized, or not affected by the ACEA. These results indicate that endocannabinoid and muscarinic modulatory effects involve similar mechanisms of action.


Assuntos
Ácidos Araquidônicos/farmacologia , Carbacol/farmacologia , Agonistas Colinérgicos/farmacologia , Colágeno/agonistas , Neurônios/fisiologia , Núcleo Tegmental Pedunculopontino/fisiologia , Fragmentos de Peptídeos/agonistas , Animais , Potenciais da Membrana/efeitos dos fármacos , Camundongos , Neurônios/efeitos dos fármacos , Núcleo Tegmental Pedunculopontino/efeitos dos fármacos
9.
Mol Biol Rep ; 42(7): 1225-32, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25682268

RESUMO

Adipose tissue remodeling by the matrix metalloproteases (MMPs) is critical for tissue hypertrophy and obesity. MMP-13 is an important protein that is highly expressed in adipose tissue but whose potential role in adipose tissue expansion is poorly characterized. We investigated the effect of pharmacological inhibition of MMP-13 with a selective inhibitor, CP-544439, on adipose tissue mass in mice on a high fat diet, and determined the effect of the inhibitor during in vitro adipocyte differentiation of 3T3-L1 cells. CP-544439 was administered for 6 weeks to mice on a high fat diet. Body adiposity and glucose tolerance was determined. Differentiating 3T3-L1 adipocytes were also treated with the inhibitor for a maximum of 8 days and adipogenesis assessed. Treatment of mice with the inhibitor resulted in reduction in body adiposity and improvement in glucose clearance. Histological examination of epididymal adipose showed reduced adipocyte hypertrophy accompanied by increased staining for collagen in the inhibitor treated mice. Treatment of differentiating 3T3-L1 cells with the inhibitor resulted in reduced adipocyte differentiation. Knockdown of MMP-13 using small interfering RNA in differentiating 3T3-L1 cells reduced adipocyte differentiation indicated by reduced expression of PPARγ. These results suggest that MMP-13 may play a major role in adipose development and its inhibition could be a potential strategy to prevent obesity.


Assuntos
Adipócitos/efeitos dos fármacos , Adipogenia/efeitos dos fármacos , Tecido Adiposo/efeitos dos fármacos , Ácidos Hidroxâmicos/farmacologia , Metaloproteinase 13 da Matriz/genética , Inibidores de Metaloproteinases de Matriz/farmacologia , Obesidade/prevenção & controle , Sulfonamidas/farmacologia , Células 3T3-L1 , Adipócitos/enzimologia , Adipócitos/patologia , Tecido Adiposo/enzimologia , Tecido Adiposo/patologia , Animais , Peso Corporal/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Colágeno/agonistas , Colágeno/genética , Colágeno/metabolismo , Dieta Hiperlipídica , Regulação da Expressão Gênica , Teste de Tolerância a Glucose , Masculino , Metaloproteinase 13 da Matriz/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Obesidade/enzimologia , Obesidade/etiologia , Obesidade/patologia , PPAR gama/antagonistas & inibidores , PPAR gama/genética , PPAR gama/metabolismo , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Transdução de Sinais
10.
Nat Commun ; 5: 5797, 2014 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-25504335

RESUMO

Systemic sclerosis (SSc) is manifested by fibrosis, vasculopathy and immune dysregulation. So far, a unifying hypothesis underpinning these pathological events remains unknown. Given that SSc is a multifactorial disease caused by both genetic and environmental factors, we focus on the two transcription factors, which modulate the fibrotic reaction and are epigenetically suppressed in SSc dermal fibroblasts, Friend leukaemia integration 1 (Fli1) and Krüppel-like factor 5 (KLF5). In addition to the Fli1 silencing-dependent collagen induction, the simultaneous knockdown of Fli1 and KLF5 synergistically enhances expression of connective tissue growth factor. Notably, mice with double heterozygous deficiency of Klf5 and Fli1 mimicking the epigenetic phenotype of SSc skin spontaneously recapitulate all the three features of SSc, including fibrosis and vasculopathy of the skin and lung, B-cell activation and autoantibody production. These studies implicate the epigenetic downregulation of Fli1 and KLF5 as a central event triggering the pathogenic triad of SSc.


Assuntos
Autoanticorpos/biossíntese , Linfócitos B/metabolismo , Fatores de Transcrição Kruppel-Like/genética , Proteína Proto-Oncogênica c-fli-1/genética , Escleroderma Sistêmico/genética , Pele/metabolismo , Animais , Autoimunidade , Linfócitos B/imunologia , Linfócitos B/patologia , Vasos Sanguíneos/imunologia , Vasos Sanguíneos/metabolismo , Vasos Sanguíneos/patologia , Estudos de Casos e Controles , Colágeno/agonistas , Colágeno/genética , Colágeno/imunologia , Fator de Crescimento do Tecido Conjuntivo/agonistas , Fator de Crescimento do Tecido Conjuntivo/genética , Fator de Crescimento do Tecido Conjuntivo/imunologia , Modelos Animais de Doenças , Epigênese Genética , Fibroblastos/imunologia , Fibroblastos/metabolismo , Fibroblastos/patologia , Fibrose , Humanos , Fatores de Transcrição Kruppel-Like/antagonistas & inibidores , Fatores de Transcrição Kruppel-Like/imunologia , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/patologia , Ativação Linfocitária , Camundongos , Camundongos Transgênicos , Proteína Proto-Oncogênica c-fli-1/antagonistas & inibidores , Proteína Proto-Oncogênica c-fli-1/imunologia , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Escleroderma Sistêmico/imunologia , Escleroderma Sistêmico/metabolismo , Escleroderma Sistêmico/patologia , Transdução de Sinais , Pele/imunologia , Pele/patologia
11.
Klin Khir ; (1): 23-5, 2012 Jan.
Artigo em Ucraniano | MEDLINE | ID: mdl-22642083

RESUMO

There were analyzed the results of treatment of 112 patients, suffering postoperative abdominal hernia, in whom the anterior abdominal wall alloplasty was performed as well as postoperative pathogenetically substantiated complex therapy, taking into account the presence of a connective tissue dysplasia syndrome (CTDS) and the early and late postoperative complications prophylaxis. The peculiarities of postoperative period course and late follow-up results were studied up. Phenotypic features of CTDS were revealed in 53 (47.3%) patients, immunohistochemical features of a connective tissue dysplasia (a failed collagen type I and III ratio, manifested by increase of a collagen type III fibers quantity in 3 or more times) were revealed in 78 (69.6%) patients, in whom the processes of a collagen and its supermolecular formations synthesis were stimulated, using a magnesium orotate (Magnerot), which was prescribed in 1 g dose twice a day during 4 - 6 weeks. Application of composite nets, owing big pores, in a complex with a postoperative pathogenetically substantiated therapy conduction have positively influenced the disease course and the late follow-up results achieved.


Assuntos
Tecido Conjuntivo/transplante , Hérnia Abdominal/tratamento farmacológico , Complicações Pós-Operatórias/tratamento farmacológico , Parede Abdominal/patologia , Parede Abdominal/cirurgia , Colágeno/agonistas , Colágeno/biossíntese , Tecido Conjuntivo/efeitos dos fármacos , Seguimentos , Hérnia Abdominal/patologia , Hérnia Abdominal/cirurgia , Humanos , Imuno-Histoquímica , Ácido Orótico/administração & dosagem , Ácido Orótico/análogos & derivados , Ácido Orótico/uso terapêutico , Complicações Pós-Operatórias/cirurgia , Período Pós-Operatório , Telas Cirúrgicas , Transplante Homólogo
12.
Thromb Res ; 123(2): 316-23, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18657307

RESUMO

INTRODUCTION: In South Africa coronary artery disease (CAD) is less common in African than Indian or white subjects. Although the association between CAD and metabolic factors have been well documented, the role of genetic factors is as yet poorly understood. Specific polymorphisms in the platelet membrane glycoprotein (GP) IIIa gene Pl(A1/A2), have been implicated in the development of CAD. METHODS: The prevalence of platelet GPIIIa (Pl(A1/A2)) polymorphisms and their effect on platelet function was determined in 313 Indian, 267 white and 227 African subjects with and without a history of CAD. RESULTS: In subjects without a history of CAD the frequency of the unfavourable Pl(A2) allele was 8.0%, 14.8% and 8.7% in the Indian, white and African populations respectively, with the frequency being significantly higher (p<0.05) in the white than both other groups. The frequency of the Pl(A2) allele was higher in subjects with (23.0%) than without (10.0%; p<0.0001) a history of CAD. Aggregation studies showed that platelets carrying the Pl(A2) allele were hypersensitive to the platelet aggregating agonists ADP and collagen and produced a higher amount of TXA(2) when stimulated with low concentrations of both these agonists. CONCLUSIONS: The positive association observed between the platelet GPIIIa Pl(A1/A2) polymorphism and platelet function suggests that the GPIIIa Pl(A2) allele may be a genetic factor that contributes to the risk of sudden death from myocardial infarction in the absence of known risk factors but it does not explain ethnic differences in the prevalence of CAD.


Assuntos
Plaquetas/metabolismo , Etnicidade/genética , Integrina beta3/genética , Polimorfismo Genético , Difosfato de Adenosina/agonistas , Difosfato de Adenosina/farmacologia , Alelos , Colágeno/agonistas , Colágeno/farmacologia , Doença da Artéria Coronariana/genética , Doença da Artéria Coronariana/metabolismo , Relação Dose-Resposta a Droga , Feminino , Frequência do Gene , Genótipo , Humanos , Masculino , Agregação Plaquetária/fisiologia , Prevalência , África do Sul/etnologia , Tromboxano A2/análise , Tromboxano A2/biossíntese , Tromboxano A2/metabolismo , População Urbana
13.
Blood ; 102(4): 1307-15, 2003 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-12738679

RESUMO

The alpha2beta1 integrin is a major collagen receptor on platelets. Although it has been proposed that alpha2beta1, like alphaIIbbeta3, undergoes agonist-induced activation, neither the potential contributions of alpha2beta1 receptor/ligand internalization to the increase in ligand binding nor the roles of the alpha2 and beta1 cytoplasmic domains in activation of this integrin have been previously explored. Activation of alpha2beta1 was assessed with fluorescein isothiocyanate-labeled soluble type I collagen binding to platelets by flow cytometry. Although collagen internalization in response to agonist activation of platelets was significant, agonist-induced collagen binding still occurred under conditions that block internalization, with minimal changes in cell surface alpha2beta1 expression. Introduction of cell-permeable peptides containing the alpha2 cytoplasmic tail, and especially the membrane proximal KLGFFKR domain, induced alpha2beta1 activation in resting platelets, whereas a cell-permeable peptide containing the beta1 cytoplasmic tail was without effect. Thus, collagen binding to stimulated platelets is increased due to alpha2beta1 activation, in addition to internalization, and the GFFKR motif appears to play an important role in the activation process.


Assuntos
Plaquetas/metabolismo , Colágeno/metabolismo , Integrina alfa2beta1/metabolismo , Ativação Plaquetária/fisiologia , Sequência de Aminoácidos , Plaquetas/fisiologia , Membrana Celular/metabolismo , Permeabilidade da Membrana Celular , Colágeno/agonistas , Citoplasma/metabolismo , Citometria de Fluxo , Fluoresceína-5-Isotiocianato/química , Fluoresceína-5-Isotiocianato/metabolismo , Humanos , Integrina alfa2beta1/genética , Ligantes , Dados de Sequência Molecular , Oligopeptídeos/farmacologia , Ativação Plaquetária/efeitos dos fármacos , Ligação Proteica , Estrutura Terciária de Proteína
14.
J Biol Chem ; 277(43): 40528-35, 2002 Oct 25.
Artigo em Inglês | MEDLINE | ID: mdl-12186858

RESUMO

The integrins alpha(2)beta(1) and alpha(1)beta(1) have been shown to modulate cellular activities of fibroblasts on contact with fibrillar collagen. Previously it has been shown that collagen binding to alpha(2)beta(1) regulates matrix metalloproteinase MMP-1 and membrane-type MT1-MMP expression. Jararhagin is a snake venom metalloproteinase of the Reprolysin family of zinc metalloproteinases, containing a metalloproteinase domain followed by disintegrin-like and cysteine-rich domains. Jararhagin blocks type I collagen-induced platelet aggregation by binding to the alpha(2)beta(1) integrin and inhibiting collagen-mediated intracellular signaling events. Here we present evidence that, in contrast to the observations in platelets, jararhagin binding to the integrin receptor alpha(2)beta(1) in fibroblasts produces collagen-like cell signaling events such as up-regulation of MMP-1 and MT1-MMP. Inactivation of the metalloproteinase domain had no effect on these properties of jararhagin. Thus, in fibroblasts the snake venom metalloproteinase jararhagin functions as a collagen-mimetic substrate that binds to and activates integrins. Given the homology between the metalloproteinase, disintegrin-like and cysteine-rich domains of jararhagin and those of the members of the ADAMs (a disintegrin-like and metalloproteinase) family of proteins, this work demonstrates the potential of the disintegrin-like/cysteine-rich domains in the ADAMs as cellular signaling agents to elicit responses relevant to the biological function of these proteins.


Assuntos
Adesão Celular/efeitos dos fármacos , Colágeno/agonistas , Venenos de Crotalídeos/farmacologia , Metaloendopeptidases/farmacologia , Transdução de Sinais/efeitos dos fármacos , Células Cultivadas , Venenos de Crotalídeos/metabolismo , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Humanos , Integrina alfa2beta1/metabolismo , Metaloproteinases da Matriz/biossíntese , Metaloproteinases da Matriz/genética , Metaloendopeptidases/metabolismo , RNA Mensageiro/genética , Venenos de Serpentes/enzimologia , Veneno de Bothrops jararaca
15.
Artigo em Inglês | MEDLINE | ID: mdl-9507752

RESUMO

Chemically modified hemoglobins are potential oxygen-carrying blood substitutes, but their in vivo administration has been associated with a variety of unexpected side events, including increased platelet reactivity. We studied the effects of hemoglobin A0 (HbA0) and alpha-crosslinked hemoglobin (alpha-DBBF) on platelets in vitro. Neither hemoglobin A0 nor alpha-DBBF activated platelets when added alone, but both proteins potentiated submaximal agonist-induced platelet aggregation without increasing other markers of platelet activation such as serotonin secretion. Only agonists that are known to cause release of platelet arachidonic acid (AA) were potentiated while aggregation induced by ADP, which does not release AA, was not potentiated. Blockade of the thromboxane receptor with SQ-29,548 prevented the HbA0-induced and the alpha-DBBF-induced potentiation suggesting that the AA/thromboxane signaling pathway mediates the interaction of platelets with hemoglobin.


Assuntos
Aspirina/análogos & derivados , Plaquetas/química , Hemoglobina A/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Receptores de Tromboxanos/sangue , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico/agonistas , Ácido Araquidônico/agonistas , Ácido Araquidônico/metabolismo , Aspirina/farmacologia , Substitutos Sanguíneos/farmacologia , Colágeno/agonistas , Colágeno/efeitos dos fármacos , Sinergismo Farmacológico , Heme/farmacologia , Humanos , Proteínas de Membrana/efeitos dos fármacos , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/efeitos dos fármacos , Receptores de Prostaglandina/efeitos dos fármacos , Receptores de Tromboxano A2 e Prostaglandina H2 , Sistemas do Segundo Mensageiro/efeitos dos fármacos , Trombina/efeitos dos fármacos , Trombina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...